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Results
Out of 93 suspected malaria cases, 37 cases were found to be positive for P. falciparum infection. [5] The epidemiological observation revealed that the study participants were mostly dependent on forest for different activities such as firewood and food. They are supposed to carrying the malaria parasites from forest areas. They were not aware of the transmission and cause of malaria. Furthermore, they are not using mosquito nets during the time of sleeping. All the study participants belong to male category. Low haemoglobin level, mean cell volume, mean corpuscular haemoglobin, mean corpuscular haemoglobin concentration and high platelet distribution widths were recorded amongst the study participants. Normal level of serum ferritin concentration was found in all cases indicating that ferritin has no role in the malaria severity.
discussion
Antimalarial resistance-associated mutations in Pfcrt, Pfdhfr and Pfdhps gene were already confirmed by many previous studies in different parts of India. [1] [2] [3] [4] [5] However, only limited reports are available on multiple drug-resistant malaria parasites having mutations in Pfcrt, Pfdhfr and Pfdhps gene in NE states of India. [2, [6] [7] [8] Our study has revealed multiple mutations in Pfcrt, Pfdhfr and Pfdhps gene, and it confirmed that SP drug will no longer effective in the treatment of malaria cases in these areas. Due to the continuous SP drug pressure, malaria parasites have evolved a certain mechanism to get rid of the toxicity of drugs. Hence, alternative option is needed in this aspect. The government of India has introduced artemisinin-based combination therapy (SP drug along with artemisinin) for the treatment of malaria cases since 2010. [9] However, due to the constant increase in SP resistance P. falciparum malaria parasites in NE states, it is believed that the artemisinin-based combination therapy will be no longer effective for treatment of malaria cases. Interestingly, the K76T mutation in Pfcrt gene was not observed from any of the multiple mutant P. falciparum cases. Instead of that, few novel mutations at 76 codon position in Pfcrt gene (K76N, K76I) were detected. However, it is not clear whether this mutation is associated with CQ resistance or not. Further studies on molecular surveillance along with clinical trial and in vitro tests assays are required in this region to know the role of K76N/K76I mutations in CQ resistance/sensitivity. From this study, it is believed that due to the continuous exposure of SP antimalarials, the parasites have developed resistance competency to it, and at the same time, they response against CQ due to the non-exposure of the drug since a long time. Apart from this, it is very worrying that the same patient has developed mutations in Pfcrt, Pfdhfr, Pfdhps and PfATPase6 together, and it may be associated with resistance to CQ, SP and artemisinin also. Hence, this combination therapy (SP drug along with artemisinin) should be replaced urgently by alternative drugs in those areas. In the same time, the clinicians should also prescribe artemether-lumefantrine combination [10] (newly introduced by the Government of India in 2013 for NE region) therapy for treatment of P. falciparum malaria cases in NE states of India, especially in most vulnerable areas.
conclusion From the study, it is confirmed that multiple drug-resistant P. falciparum malaria parasites are prevalent in certain parts of NE states in India.
